Psychedelic Drugs: Global Market Outlook

May 2023| PHM270A| BCC Publishing

Report Highlights

The report provides an overview of the global psychedelic drugs market. This report includes sales forecasts and trends in the market for psychedelic drugs through 2027. It discusses leading companies in the market, product segments, supporting technologies, market dynamics, competitive intelligence and regional trends.

Report Includes

  • 12 data tables and 9 additional tables
  • A brief general outlook of the global market for psychedelic drugs within the biopharmaceutical industry
  • Analyses of the global market trends, with historic sales data for 2021, estimates for 2022, and projections of compound annual growth rates (CAGRs) through 2027
  • Highlights of the current and future market potential of psychedelic drugs, along with detailed analyses of the competitive environment, regulatory scenario, pipeline analysis, technological advancement and market dynamics
  • Estimation of the actual market size and revenue forecast for global psychedelic drugs market in USD million values, and corresponding market share analysis based on drug type, application, and region
  • Information on stringent regulatory policies and government guidelines to impede the adoption rate of the psychedelic drugs
  • Review of key marketed and pipelined products indicated for different therapeutic applications, clinical trials, and penetration of technologies and research initiatives within the ecosystem
  • Company profiles of major players within the industry, including Pfizer Inc., Celon Pharma, Cybin Corp., Jazz Pharmaceuticals Inc., and PharmaTher Holdings Ltd.

Report Scope

This report includes sales forecasts and trends in the market for psychedelic drugs through 2027. It discusses leading companies in the market, product segments, supporting technologies, market dynamics, competitive intelligence and regional trends. It also discusses market the competitive scenarios that will form the base data for qualitative analysis and market estimates.

In this report, the global market for psychedelic drugs is segmented into four geographic regions: North America, Europe, Asia and RoW (South America, the Middle East and Africa).

Frequently Asked Questions (FAQs)

The psychedelic drugs market is projected to grow from $3.7 billion in 2021 to $5.7 billion in 2027, at a compound annual growth rate (CAGR) of 7.5% during the forecast period.
The key factors driving the growth of psychedelic drugs market includes
  • Growing scientific support for the development of psychedelic drugs
  • Regulatory advancements
  • Increasing patient and physician acceptance
The psychedelic drugs market is segmented based on drug type, application, and region.
Ketamine segment will dominate the market by the end of 2027.
North America holds the highest share in the market.
Key companies in the market includes Pfizer Inc, Celon Pharmaceuticals, Cybin Corp, Jazz Pharmaceuticals, PharmaTher Holdings.

Analyst Credentials

BCC Research Team possesses expertise and experience in life and physical science domains. They specialize in offering valuable business insights, including industry analysis, competitor intelligence, strategic and financial analysis, and opportunity assessment. The team has in-depth knowledge of various sectors, including healthcare, biotechnology, pharmaceuticals, IT, automation, advanced materials, and energy. They are proficient in qualitative and quantitative market intelligence providing clients with actionable insights. With a vast understanding of the competitive landscape, the team can support clients in making data-driven decisions to help them achieve a competitive edge in their respective markets.

Report Synopsis

Report Metrics Details
Base year considered 2021
Forecast period considered 2022-2027
Base year market size $3.6 billion
Market size forecast $5.6 billion
Growth rate CAGR of 7.5% for the forecast period of 2022-2027
Units considered $ Millions
Segments covered Drug Type, Application, Region
Regions covered North America, Europe, Asia-Pacific, Rest of the World (RoW)
Key Market Drivers
  • Growing scientific support for the benefits of psychedelic drugs
  • Regulatory advancements
  • Increasing acceptance by patients and physicians
Companies studied
  • CELON PHARMA S.A.
  • CYBIN CORP.
  • HIKMA PHARMACEUTICALS PLC.
  • JAZZ PHARMACEUTICALS INC.
  • MIND MEDICINE INC.
  • PFIZER INC.
  • PHARMATHER HOLDINGS LTD.
  • REVIVE THERAPEUTICS LTD.

Table of Contents

All reports provided in PDF format. For shared licensing options (5+ Users), please call a representative at (+1) 781-489-7301 or contact us at info@bccresearch.com
Title/Chapter NamePagesMember Price
Full Report: Psychedelic Drugs: Global Market Outlook35Free
Psychedelic Drugs: Global Market Outlook

Single User License: $3500

Become a Member

Already a member? Login to access this report free.

Have a Question? Ask Us.

Why BCC Research.?

Every purchase provides access to:

  • Thousands of recently published reports from select publishers
  • Member Discounts of up to 50% on over 20,000 additional reports from all publishers
  • Our analysts and research concierge for all inquiries
Custom Research

Need a custom data table, graph or complete report? Tell us more.

RELATED REPORTS